Oxybutynin Hydrochloride Accord Healthcare (Oxybutynin Hydrochloride)

Oxybutynin Hydrochloride is used in the management of urinary disorders that involve involuntary bladder contractions.

• Overactive bladder: reduces urgency and frequency of urination.
• Urge urinary incontinence: decreases episodes of involuntary urine loss.
• Neurogenic bladder dysfunction: helps control bladder spasms associated with neurological conditions.

• Oxybutynin hydrochloride competitively blocks muscarinic M3 receptors in the detrusor muscle of the bladder, reducing acetylcholine‑mediated contractions. This anticholinergic action relaxes the bladder wall, increasing functional capacity and decreasing involuntary detrusor overactivity associated with overactive bladder and related disorders.

Oxybutynin Hydrochloride may cause a range of adverse reactions, most of which are mild to moderate and resolve with continued therapy or dose adjustment.

Common Side Effects

• Dry mouth: sensation of oral dryness.
• Constipation: reduced bowel movement frequency.
• Blurred vision: temporary visual disturbance.
• Drowsiness: mild sedation or fatigue.
• Urinary retention: difficulty initiating urination.

Serious or Rare Side Effects

• Acute angle‑closure glaucoma: sudden eye pain and visual loss.
• Severe constipation leading to bowel obstruction.
• Cardiac arrhythmias: irregular heart rhythm.
• Hepatic dysfunction: elevated liver enzymes.
• Allergic reactions: rash, itching, swelling, or anaphylaxis.

Before initiating therapy with Oxybutynin Hydrochloride, consider the following precautions to ensure safe use.

• Assess renal function: dose may need adjustment in severe impairment.
• Evaluate hepatic function: monitor for signs of liver injury.
• Review glaucoma history: avoid in patients with narrow‑angle glaucoma.
• Monitor for urinary retention: especially in men with prostate enlargement.
• Caution in the elderly: increased sensitivity to anticholinergic effects.
• Store at ambient temperature: keep below 25°C, protect from moisture and light.

Oxybutynin Hydrochloride can interact with several medicines, altering its efficacy or safety profile. Major Interactions (Avoid):\n- Ketoconazole: may increase oxy‑cysteine ??

• Strong CYP3A4 inhibitors: elevate plasma concentrations of oxybutynin.
• Anticholinergic drugs: additive anticholinergic burden.

Moderate Interactions (Monitor Closely)

• Antihistamines: may enhance dry‑mouth effects.
• Tricyclic antidepressants: increase risk of urinary retention.
• Digoxin: potential increase in serum digoxin levels.
• Alcohol: may intensify drowsiness and dizziness.
• Beta‑beta  

g